Double edged sword. Could be something wrong on the manufacturing side also. Company should clarify if it is really incresed demand.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025